160.81
-4.17(-2.53%)
Currency In USD
| Previous Close | 164.98 |
| Open | 163.68 |
| Day High | 164.54 |
| Day Low | 160.1 |
| 52-Week High | 182.52 |
| 52-Week Low | 102.97 |
| Volume | 493,864 |
| Average Volume | 946,569 |
| Market Cap | 9.05B |
| PE | 8,040.5 |
| EPS | 0.02 |
| Moving Average 50 Days | 152.95 |
| Moving Average 200 Days | 134.72 |
| Change | -4.17 |
If you invested $1000 in Repligen Corporation (RGEN) 10 years ago, it would be worth $5,860.42 as of December 09, 2025 at a share price of $160.81. Whereas If you bought $1000 worth of Repligen Corporation (RGEN) shares 5 years ago, it would be worth $899.49 as of December 09, 2025 at a share price of $160.81.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Repligen Corporation to Present at Evercore Healthcare Conference
GlobeNewswire Inc.
Nov 26, 2025 12:30 PM GMT
WALTHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participate in the 8th Annual Evercore Healthcare Conferen
Repligen Corporation to Present at Upcoming November Conferences
GlobeNewswire Inc.
Nov 04, 2025 12:30 PM GMT
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming investor conferences. The UBS Glob
Repligen to Report Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Oct 15, 2025 11:30 AM GMT
Webcast and Conference Call to Be Held Tuesday, October 28, 2025, at 8:30 a.m. ETWALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial resu